Home Tags Bispecifics

Tag: Bispecifics

What are the latest technologies being used to develop ADCs?

Rakesh Dixit, Ph.D, DABT
Targets Most targets of ADC have unique requirements, including  homogenous expression of ADC-accessible tumor surface antigens that internalize well and trafficked to lysosomes.  Ideally the...

Merus Therpeutics: Seeking to Advance Immuno-Oncology

Sonia Portillo
In Oncology, many new developments of the last decade have made it possible to treat cancers in ways that are better-targeted, more potent, and...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X